Instituto de Investigación Sanitaria Biobizkaia-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2023

  1. m6A levels and expression of its modification genes show significant differences in breast cancer molecular subtypes

    Genes and Diseases, Vol. 10, Núm. 5, pp. 1751-1754

2022

  1. In silico identification and in vitro expression analysis of breast cancer-related m6A-SNPs

    Epigenetics, Vol. 17, Núm. 13, pp. 2144-2156

2021

  1. A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer’s Disease

    Molecular Neurobiology, Vol. 58, Núm. 1, pp. 55-64

2015

  1. Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOEε4 Allele

    Disease Markers, Vol. 2015

  2. Erratum to: Potential relationship between single nucleotide polymorphisms used in forensic genetics and diseases or other traits in European population[Int J Legal Med (2015) 129,435-443, DOI 10.1007/s00414-015-1165-7]

    International Journal of Legal Medicine

  3. Potential relationship between single nucleotide polymorphisms used in forensic genetics and diseases or other traits in European population

    International Journal of Legal Medicine, Vol. 129, Núm. 3, pp. 435-443

2013

  1. Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ε4 carriers: A case-control study

    BMJ Open, Vol. 3, Núm. 9